SUPERFLEX
Report
- Report Number
- 9611165-2012-00026
- Event Type
- Injury
- Date Received
- June 6, 2012
- Date of Event
- October 1, 2011
- Report Date
- April 4, 2012
- Manufacturer
- RAYNER INTRAOCULAR LENSES LTD.
- Product Code
- HQL
- PMA / PMN Number
- P060011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
THE REFERENCE (B)(4) HAS BEEN ALLOCATED TO THIS EVENT BY RAYNER INTRAOCULAR LENSES LIMITED. THE DEVICE ANALYSIS PERFORMED BY AN INDEPENDENT THIRD PARTY TESTING FACILITY CONFIRMED THAT THERE WERE CRYSTALLINE DEPOSITS DIRECTLY BELOW THE INTRAOCULAR LENS SURFACE HOWEVER, COULD NOT ASCERTAIN THE ROOT CAUSE OF THE DEVELOPMENT OF OPACIFICATION. THE PHYSICIAN COMMENTED IN HIS CORRESPONDENCE WITH RAYNER INTRAOCULAR LENSES LIMITED THAT "SURGERY WAS NOT STRAIGHT FORWARD (IN TERMS OF NEEDING A SECOND INJECTION OF AIR INTO THE ANTERIOR CHAMBER OR OF THE SURGERY BEING A REPEAT CORNEAL ENDOTHELIAL GRAFT, ETC). MY HUNCH IS THAT BREAKDOWN OF THE NORMAL BLOOD-AQUEOUS BARRIER HAS SOMETHING TO DO WITH IT." OUR REVIEW OF PRODUCTION RECORDS FOR THE SUPERFLEX 620H BATCH 118E85260 CONFIRMS THAT ALL MANUFACTURING AND QUALITY CHECKS WERE SATISFACTORY. ALL LENSES RELEASED FROM THIS BATCH WERE WITHIN SPECIFICATION. COMPLAINTS SINCE (B)(4) 2008, THE MONTH OF MANUFACTURE, WERE REVIEWED AND WE CAN CONFIRM THAT NO COMPLAINTS, OF ANY TYPE, HAVE BEEN RECEIVED AGAINST THE SUPERFLEX 620H BATCH 118E85260. THERE IS NO INDICATION FROM THE RESULTS OF THE ANALYSIS OR OF OUR PRODUCTION RECORD REVIEW THAT THIS EVENT HAS OCCURRED AS A RESULT OF A DEVICE DEFECT OR MALFUNCTION.
RAYNER INTRAOCULAR LENSES LIMITED WERE NOTIFIED BY (B)(6) HOSPITAL (B)(6) ABOUT A SUSPECTED OPACIFICATION CASE WITH A PT WHO RECEIVED A RAYNER INTRAOCULAR LENS FOLLOWING CORNEAL ENDOTHELIAL GRAFT SURGERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SUPERFLEX | HQL - INTRAOCULAR LENS | HQL | RAYNER INTRAOCULAR LENSES LTD. | 620H | 118E85260 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |